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Abstract
Introduction: Alström Syndrome is a rare disease caused by mutations in ALMS1 gene. It is char-
acterized by a progressive degeneration of sensory functions, resulting in visual and audiologi-
cal impairment, as well as metabolic disturbances such as childhood obesity, hyperinsulinemia, 
and diabetes mellitus type 2. 
Objective: To report and discuss the genetic and audiological findings in two siblings with 
Alström syndrome. 
Methods: This was a prospective, analytical and descriptive study, using questionnaires, serial 
audiograms, otoacoustic emissions, and auditory brainstem response analysis, as well as mo-
lecular genetic analysis. 
Results: Both patients presented childhood-onset bilateral sensorineural hearing loss, which pro-
gressed to moderate impairment in the first case and severe hearing loss in the second. Otoacoustic 
emissions were absent, and auditory brainstem responses were bilaterally normal in both cases. 
Conclusion: In the present patients, Alström Syndrome began with a neurosensory hearing loss 
in early childhood that progressed to a profound loss in ten to twenty years. The auditory le-
sions were cochlear in origen according to the otoacoustic emissions and auditory brainstem 
responses.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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Síndrome de Alström familiar: uma rara causa de perda auditiva progressiva bilateral
Resumo
Introdução: A Síndrome de Alstrom é uma doença muito rara, causada pela mutação no gene 
ALMS1, que apresenta uma degeneração progressiva das funções sensoriais, resultando em de-
ficiências visuais e auditivas, além de distúrbios metabólicos como obesidade na infância, hipe-
rinsulinemia e diabetes tipo II. 
Objetivo: Apresentar o perfil audiométrico de dois irmãos da mesma família afetados pela 
Síndrome de Alström. 
Please cite this article as: Bahmad F Jr., Costa CS, Teixeira MS, Barros-Filho J, Viana LM, Marshall J. Familial Alström syndrome: a rare 
cause of bilateral progressive hearing loss. Braz J Otorhinolaryngol. 2014;99-104.
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Introduction
According to Alström et al.,1 Alström syndrome is a genetically 
transmitted disease with a variety of symptoms that include 
progressive sensory degeneration, resulting in visual and audi-
tory deficits, as well as obesity. Metabolic, endocrine, renal, 
cardiac, and hepatic dysfunctions are also observed.
Descriptions of clinical cases of Alström syndrome are scar-
ce. The first significant scientific article was published  by Eggitt 
Russell et al.,2 who performed a longitudinal study of 22 cases 
of Alström syndrome, focusing on the histopathology of affected 
organs and other factors that led to the death of the affected 
patients. Marshall et al.3 studied 182 cases of the syndrome. 
According to Welsh et al.,4 the genetic factor that causes the 
syndrome was a reciprocal translocation in a novel gene of unk-
nown function, ALMS1, located on chromosome 2p13. 
Even though Alström syndrome has been described as 
a homogeneous alteration resulting from a mutation in a 
single gene, families have been described with variable cli-
nical presentations. Cardiomyopathy, hepatic dysfunction, 
hypothyroidism, and hypogonadism can occur. These symp-
toms vary in individuals from the same family, due to the 
interactions of genetic modifiers.1 Collin et al.5,6 indicated 
that the phenotype of Alström syndrome is due to an altered 
function, rather than inadequate organ development.
Alström et al.1 reported the onset of hearing loss in pa-
tients affected by the syndrome before the age of 10 years and 
noted subsequent progression. Michaud et al.7 confirmed that 
deafness began in the first decade of life. Marshall et al.3 indi-
cated that hearing loss appeared during childhood and that the 
mean age of onset was 5 years. Coincidentally, chronic serous 
otitis media was observed in 42% of their patients, adding a 
conductive component to the already described sensorineural 
loss.7 Russell-Eggitt et al.2 reported that only two of their 22 
cases had normal hearing after 12 years of age. 
The present study aimed to perform an extensive litera-
ture review and to present a complete clinical-audiometric 
profile, and molecular genetic analysis of two siblings, the 
only two cases reported to date in South America, in order 
to provide a better understanding of this very rare disease. 
Material and methods
A prospective, descriptive analytic study of the phenotype 
of a Caucasian Brazilian family with members affected by 
Alström syndrome, was conducted. Data were collected 
through a long-term clinical evaluation of patients, chart 
review, and a questionnaire answered by family members. 
Patients underwent a complete otorhinolaryngological 
assessment with audiological examination with pure-tone 
and speech audiometry, acoustic immitance testing, distor-
tion-product otoacoustic emissions (DPOAE), transient-e-
voked otoacoustic emission (TEOAE), and auditory brains-
tem response (ABR) testing. 
Pure tone audiometry by air  conduction was performed, 
at frequencies from 250 to 8,000 Hz, and by bone conduction 
at frequencies from 500 to 4,000 Hz;  speech recognition and 
speech reception thresholds were measured using GSI68 equi-
pment, equipped with TDH-39 earphones. Tympanometry was 
performed using GSI38 equipment. The criteria proposed by 
Russo and Santos were employed for this assessment.8
DPOAE and TEOAE were performed using a Biologic equip-
ment (Scout model). Amplitudes and signal/noise ratio were 
evaluated in both ears, based on the criteria described by 
Figueiredo9 and by Gorga.10 ABR was performed in a Biologic 
equipment (Navigator-Pro model). The electrodes were pla-
ced according to the international electrode system:11 the 
active electrode on the vertex (Cz); the ground, on the fo-
rehead (Fz); and the reference electrodes on the lobes of the 
right and left ears (A1 and A2). The headphone used in the 
test was the TDH-39. The type of stimulus was a click with an 
intensity of 80 dB HL. Absolute latencies of waves I, III, and V 
were measured, as well as interpeak intervals of waves I-III, 
III-V, and I-V, and binaural comparison of wave V latencies. 
The Hood criteria were used for this assessment.12
To perform the molecular genetic diagnosis, an in-
formed consent was obtained from all patients involved 
in the study and their parents/guardians. This study was 
approved by the research ethics committee of the ins-
titution, under protocol number 1112000005. Genomic 
DNA, isolated from peripheral blood according to the 
standard method, was amplified using the polymerase 
chain reaction (PCR) protocol, as previously described.10 
Sequences of primers and amplification conditions are 
available at request. PCR amplicons of exons 8, 10, and 
16 of ALMS1 gene were purified, directly sequenced, and 
Método: Estudo prospectivo, analítico descritivo, os pacientes afetados foram submetidos a um 
questionário previamente testado, audiometria tonal e vocal seriadas, análise de emissões oto-
acústicas, e de respostas de potencial evocado auditivo de tronco encefálico, além de análise 
genético-molecular para comprovação diagnóstica. 
Resultados: Ambos os pacientes apresentaram perda auditiva bilateral com o início na infância 
e progressão lenta para perda auditiva neurosensorial severa no primeiro caso e, profunda, no 
segundo. As emissões otoacústicas estavam ausentes, e o potencial evocado auditivo de tronco 
encefálico estava normal em ambos os pacientes, bilateralmente. 
Conclusão: A Síndrome de Alström apresenta início precoce de perda auditiva neurossensorial, 
antes da adolescência, 10 a 20 anos para desenvolver perda auditiva severa a profunda. A lesão 
auditiva é essencialmente coclear, de acordo com os resultados dos testes de emissões otoacús-
ticas e de potenciais evocados auditivos de tronco encefálico.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
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analyzed using an ABI 3730 Sequencing Analyzer system 
(Applied Biosystems - Forster City, CA, USA) system. The 
resulting sequences were compared with reference se-
quences from the GenBank mRNA (NM_015120.4). The 
nomenclature of the mutations was defined by den Dun-
nen and Antonarakis.11
Results
Both affected patients had progressive sensorineural dea-
fness first detected at approximately 6 years of age. Fig. 
1 presents the family’s pedigree. Computed tomography 
and magnetic resonance imaging (MRI) of the mastoid were 
performed in both patients, but revealed no abnormalities. 
Tests were negative for enlarged vestibular aqueduct or co-
chlea-saccular dysplasia. 
Genetic analysis confirmed the mutation in ALMS1 gene 
in the two brothers. Two heterozygous mutations were 
identified in ALMS1 exon 10 (c.7942C > T, Gln2648* and 
c.9163ª > T, Lys3055*), confirming the diagnosis of Alström 
syndrome. (Fig. 2) 
Patient 1 presented at age 30 years, with a history of 
photophobia since birth, nystagmus since age 6 months, and 
retinitis pigmentosa since the age of 10 months. He did not 
have a history of recurrent otitis media. He had dilated car-
diomyopathy, diagnosed at age 28 years, but no congestive 
heart failure. He had no pulmonary, hepatic, or renal symp-
toms. He had diabetes with insulin resistance diagnosed at 
age 27, in addition to hyperinsulinemia, hypertriglyceride-
mia, hypogonadism, hypothyroidism, acanthosis nigricans, 
and obesity since childhood.
Patient 1 was initially diagnosed with sensorineural hea-
ring loss of unknown genetic etiology. Cochlear function tes-
ted at age 6 years demonstrated moderate bilateral sensori-
neural deafness. Since then, he underwent serial pure tone 
and speech audiometry. Figs. 3 and 4 show the results of 
pure-tone audiograms at ages 21 and 30 years, respectively. 
These serial audiograms document a slowly progressive, 
bilateral sensorineural hearing loss. At the age of 28 years, 
hearing impairment required the use of a hearing aid bilate-
rally, with partial improvement in hearing acuity in both ears.
His most recent audiometric assessment, performed at 
30 years of age, showed a mean loss of 50 dB HL for the ri-
ght and left ears, as shown in Fig. 3. Tympanometry showed 
normal “A” curves for both ears.
Recent otoacoustic emissions tests for patient 1 reveal 
absent DPOAE and TEOAE responses in both ears. Amplitudes 
and signal/noise ratio were analyzed bilaterally and were 
below the expected values compared with normal subjects, 
compatible with altered cochlear function.
ABR performed at an intensity of 80 dB HL was normal 
for both ears, with the presence of waves I, III, and V. The 
absolute latencies of waves I, III, and V, and interpeak inter-
vals for waves I-III, III-V, and I-V were within normal limits, 
as was a binaural comparison of wave V latency.
Patient 2 presented at age 26 years and gave a history 
of, photophobia since birth, nystagmus at 6 months of life, 
and the onset of retinitis pigmentosa in childhood . He also 
had recurrent otitis with otalgia and otorrhea since early 
childhood,. He was diagnosed with dilated cardiomyopathy 
at 2 months of age, without congestive heart failure; the 
patient underwent treatment for one year, and the car-
diomyopathy completely disappeared. He experienced no 
pulmonary and renal symptoms. He had liver dysfunction 
diagnosed at age 20 years. He did not have diabetes, but 
had hyperinsulinemia, hypertriglyceridemia, hypogona-
dism, hypothyroidism, and obesity since childhood. The 
patient also did not present acanthosis nigricans. 
Patient 2 was diagnosed with sensorineural hearing loss 
of unknown genetic etiology, as was his older brother. Co-
chlear function at age 6 was tested, and was abnormal. 
Figure 1 Pedigree showing the two cases with Alström Syndro-
me (case 1: III-1 and case 2: III-3). 
Figure 2 Mutation in the ALMS1 gene.
Alström Syndrome - Results
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Since then, this patient has undergone serial assessments, 
including pure-tone and speech audiometry (Figs. 5 and 6). 
These serial audiometric assessments reveal slowly pro-
gressive, bilateral sensorineural hearing loss. At the age of 
23 years, the hearing deficit required the use of  bilateral 
hearing aids, with partial improvement in hearing acuity in 
both ears. The most recent audiogram, performed at age 26 
years, showed a mean loss of 70 dB HL for the right ear and 
65 dB HL for the left ear. Tympanometry showed the presen-
ce of “As” curves bilaterally.
DPOAE and TEOAE were absent in both ears. Amplitude 
and signal/noise ratios were analyzed bilaterally and were 
below those of normal subjects, indicating altered cochlear 
function.
Auditory brainstem response assessment at 80 dB HL 
intensity was normal in both ears, and waves I, III, and V 
were present. The absolute latencies of waves I, III, and 
V, and interpeak intervals of waves I-III, III-V, and I-V were 
within normal limits, as was a comparison of binaural wave 
V latency.
Figure 3 Audiometry in patient 1, performed at 21 years of 
age.
Figure 4 Audiometry in patient 1, performed at 30 years of 
age.
Figure 6 Audiometry in patient 2, performed at 26 years of 
age.
Figure 5 Audiometry in patient 2, performed at 11 years of 
age.
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Discussion
The limited number of reports related to Alström syndrome 
and the few cases in the world literature reflect the rarity 
of this condition. The early onset of sensorineural hearing 
loss, which can be severe as early as the third decade of 
life, is usually the most striking sign of this syndrome.
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This study assessed two members of a Caucasian family 
that had a clinical picture of slowly progressive bilateral 
sensorineural hearing loss that began at 6 years of age. Au-
diometry performed at 30 years of age in one patient and 
at 26 years in the other showed moderate and severe senso-
rineural hearing loss, respectively. DPOAE and TEOAE were 
absent, and the signal/noise ratio was below normal when 
compared with normal subjects, in both cases, while tympa-
nometry and ABR were normal. These data suggest that the 
lesion causing hearing loss was cochlear. 
The etiology of sensorineural hearing loss in childhood 
has several causes, including hereditary, infectious, and 
development-related causes, as well as other less common 
causes, such as autoimmune, traumatic, and vascular.
The hereditary causes can be divided into syndromic and 
non-syndromic; the latter is less prevalent.13 Among the 
syndromic causes, Usher syndrome is the most important 
differential diagnosis of hearing loss with early onset and 
slow progression, associated with visual loss., What is the 
best evidence to suggest Alström syndrome in patients with 
early-onset progressive sensorineural hearing loss? 
First, through serial audiometric evaluations (pure tone 
sensitivity) may  confirm a sensorineural hearing loss that 
slowly progresses  over 15 years to a profound hearing loss. 
Signs of retinopathy, easily identifiable by retinoscopy and 
confirmed by electroretinography, can also help in the diag-
nosis of the syndrome.
In addition to these audiological and visual aspects, the 
presence of metabolic disorders such as type 2 diabetes 
mellitus, hypertriglyceridemia, hypogonadism, hypothyroi-
dism, renal and hepatic dysfunction, as well as childhood 
obesity , although variably manifested among affected pa-
tients, can also aid in the differential diagnosis.
Since Alström syndrome is caused by mutations in the 
ALMS1 gene, molecular genetic analysis must be employed 
in order to confirm the clinical diagnosis.14-17 
This is the first description in the Portuguese literature 
of two members of a family affected by Alström syndrome. 
While there are still no scientific publications disclosing the 
histopathology of the cochlea in this syndrome, the authors 
suggest that behind this slowly progressive degeneration of 
the hearing function, there is a mechanism that ultimately 
leads to the destruction of hair cells in the organ of Corti. 
Although there is no preventive treatment for sensori-
neural hearing loss in patients with Alström syndrome; iden-
tification is important so family counseling can be performed. 
Additionally, follow-up by a multidisciplinary team can help 
patients achieve better educational and psychosocial develo-
pment, as well as facilitate the treatment and rehabilitation 
of associated disorders. Early identification of hearing loss and 
its prompt rehabilitation through the use of bilateral hearing 
aid devices can provide patients with better language develo-
pment and ensure that they are good candidates for hearing 
rehabilitation with the use of cochlear implant technology. 
Conclusion
After a long-term follow-up of over 20 years, it was observed 
that the audiometric profile of this syndrome is characterized 
by early onset of sensorineural hearing loss, usually in the first 
decade of life with slow progression, resulting in profound he-
aring loss in affected individuals after ten to 20 years. The 
probable site of injury is cochlear, as suggested by the analysis 
of otoacoustic emissions and auditory brainstem responses.
Notwithstanding the rarity of the syndrome, early de-
tection and treatment of hearing loss through the use of bi-
lateral hearing aid devices can allow an adequate language 
development. 
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